1. Publication
- Title: Effects of a Combined Lifestyle Intervention on Recovery of ICU Survivors: A Randomized Controlled Trial
- Acronym: None assigned
- Year & Journal: Critical Care Medicine, epublished March 16, 2026 (2026;54(6):1377-1386)
- Citation: Christiaanse PMR, van Zutphen T, Bolding HA, et al. Effects of a Combined Lifestyle Intervention on Recovery of ICU Survivors: A Randomized Controlled Trial. Crit Care Med. 2026;54(6):1377-1386. doi:10.1097/CCM.0000000000007095
2. Context & Rationale
Background: Evidence supporting combined nutrition-and-exercise programs in ICU survivors is limited, with inconsistent results across prior individual rehabilitation trials (some showing SF-36 physical function benefit, others null). Long-stay ICU survivors frequently have physical functioning (PF) deficits and reduced HRQoL that persist for a year or more post-discharge.
Research Question/Hypothesis: In long-stay ICU survivors with impaired physical functioning, does a 12-week combined lifestyle intervention (exercise, diet, protein supplementation) improve physical functioning and HRQoL compared with standard aftercare?
Why This Matters: Post-ICU physical deconditioning and reduced quality of life are common and persistent; combining exercise with nutritional support addresses both the catabolic and deconditioning components of post-ICU recovery, a combination less commonly tested than exercise alone.
3. Design & Methods
- Study Type: Single-center randomized controlled trial
- Setting & Centers: Medical Centre Leeuwarden (Frisius Medical Centre), Netherlands (teaching hospital)
- Population:
- Inclusion: Adult long-stay ICU survivors (≥48h ICU stay) with a physical functioning (PF) score <67% on the Dutch RAND-36 Health Survey
- Baseline severity: Median ICU stay 7 days (IQR 4-14), APACHE III median 67 (IQR 50-89) — a severely ill cohort
- Intervention: 12-week program: twice-weekly group exercise, dietary advice, and protein supplementation as needed
- Comparator: Standard aftercare per local protocol
- Randomization: 39 patients completed the study (20 control, 19 intervention); 26% female, median age 61 (IQR 46-72)
- Blinding: Not detailed in available trial text
- Statistical Power & Follow-Up: Primary outcome: PF score at 12 weeks (RAND-36), assessed at a clinic visit at baseline and after the 12-week period, alongside secondary outcomes.
4. Key Results
39 patients completed the study (20 control, 19 intervention) of a larger randomized cohort (trial protocol indicates a planned enrollment around 40; some imbalance in ICU characteristics between groups was noted despite similar baseline PF scores).
Outcome | Intervention | Control | Notes |
PF score at 12 weeks (primary) | Not reported as exact score/difference in accessible text | Not reported as exact score/difference in accessible text | Baseline PF scores were similar between groups per available abstract text; between-group outcome comparison not fully accessible |
Secondary HRQoL/functional outcomes | Not reported in accessible text | Not reported in accessible text | Not available in accessible source text |
Note on data completeness: This is a small (n=39 completers), single-center pilot-scale trial. Despite multiple targeted searches, the exact between-group primary-outcome result (PF score change/difference with CI and p-value) was not available in the accessible source text used for this summary. Per this handbook's data-integrity standard, this is explicitly flagged as a gap rather than estimated — readers should consult Crit Care Med. 2026;54(6):1377-1386 directly for the primary quantitative result.
5. Internal Validity Assessment
- Randomization & Allocation: Randomized design; specific concealment mechanics not detailed in available trial text.
- Protocol Adherence & Separation: Not detailed in available trial text.
- Blinding & Detection Bias: Not detailed in available trial text.
- Missing Data & Sensitivity Analyses: Notable attrition/small final sample (39 completers) relative to what was likely a larger initial randomized cohort — a significant limitation for a trial of this design.
- Overall Internal Validity Conclusion: Low-Moderate — very small completer sample size (39, with only 19 in the intervention arm) severely limits statistical power for a combined lifestyle intervention in a heterogeneous, severely ill post-ICU population; noted imbalances in ICU characteristics between groups (despite similar baseline PF scores) add further uncertainty.
6. External Validity Assessment
- Population Representativeness: Severely ill long-stay ICU survivors (median APACHE III 67) with documented physical functioning impairment (PF <67% on RAND-36) — a clinically relevant, appropriately targeted population for a rehabilitation intervention.
- Practice Context: Single Dutch teaching hospital; generalizability to other health systems' post-ICU aftercare pathways uncertain given single-center design.
- Overall External Validity Conclusion: Limited — single-center, small sample; the population selection strategy (targeting patients with objectively low PF scores) is a methodological strength for external validity to similarly-impaired survivors, but the small size limits confident generalization of any effect estimate.
7. Strengths & Limitations
Strengths:
- Combines exercise, diet, and protein supplementation — addressing multiple mechanistic pathways of post-ICU deconditioning simultaneously
- Targets a population objectively selected for physical functioning impairment (PF <67%), rather than an unselected post-ICU population
- Assesses both physical functioning and broader HRQoL outcomes
Limitations:
- Very small completer sample (n=39)
- Single-center design
- Noted baseline imbalances in ICU characteristics between groups
- Exact primary-outcome statistical results not accessible for this summary
8. Interpretation & Practice Impact
- Clinical Implications: Cannot be determined with confidence from accessible sources given the missing primary-outcome statistics; the trial's small sample size independently limits how much practice-changing weight this result can bear regardless of the point estimate.
- Mechanistic Coherence: The combined exercise-plus-nutrition approach is biologically well-motivated (addressing both muscle deconditioning and catabolic/nutritional deficits), consistent with broader ICU-acquired weakness pathophysiology.
- Systems-Level Takeaway: Given the small sample size, this trial is best viewed as hypothesis-generating/pilot-scale evidence rather than a definitive practice-changing result, pending larger confirmatory trials.
9. Controversies & Subsequent Evidence
- Editorial Commentary/Debates: Broader literature on combined nutrition-exercise ICU survivor interventions has been explicitly described by the trial's own authors as "limited," situating this trial as an early contribution to a genuinely underdeveloped evidence base.
- Guideline Integration: Not yet incorporated into major post-ICU rehabilitation guidelines at time of this handbook's compilation.
10. Summary & Executive Takeaway
Summary: This small, single-center Dutch RCT randomized long-stay ICU survivors with impaired physical functioning (RAND-36 PF <67%) to a 12-week combined exercise/diet/protein-supplementation program or standard aftercare. Only 39 patients (20 control, 19 intervention) completed the study; the exact primary-outcome (PF score at 12 weeks) result was not accessible for this summary.
Overall Takeaway: This pilot-scale trial addresses a genuine gap (combined nutrition-exercise post-ICU rehabilitation) in a population appropriately selected for physical functioning impairment, but its very small completer sample size means it should be interpreted as hypothesis-generating rather than definitive — readers should consult the primary publication directly for the quantitative result before drawing clinical conclusions.
11. Bibliography
- Beumeler LFE, van Wieren A, Buter H, et al. Patient-reported physical functioning is limited in almost half of critical illness survivors 1-year after ICU-admission. PLoS One. 2020;15(12):e0243981.